because of its uptake in the melanoma ( tumour/eye ratio 8.9 ) , 4- ( dimethylamino-ethylamino ) -7-iodoquinoline ( nm113 ) was selected for further investigations as a possible radiopharmaceutical for ocular scintigraphy when labelled with 123i .
C0015414
tumour/eye
C0015392
ocular